VivoSeq
Other

ALK

0

Pipeline Programs↗

3

Active Trials↗

4

Companies Involved↗

ALK is an early-stage landscape with 0 programs across 4 companies. The most active players are GSK, AstraZeneca, Teva.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

94/100

Attrition Rate

4/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

GSK logo

GSK

0 programs

PreclinicalAstraZeneca logo

AstraZeneca

0 programs

PreclinicalTeva logo

Teva

0 programs

PreclinicalA

AM-Pharma

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

24

clinical trials

Completed17 · 71%
Active, not recruiting3 · 13%
Unknown status3 · 13%
Terminated1 · 4%

Clinical Trials

Trial Activity

24 trials

Alkaline Water and Salivary Bacterial Count
Active, not recruiting·PPharos University in Alexandria·Phase 3·NCT06511336·60 enrolled
A Study of Auxora in Patients With AKI and Injurious Lung "Crosstalk"
Active, not recruiting·CCalciMedica, Inc.·Phase 2·NCT06374797·150 enrolled
A Comparative Study Between Preservative With Benzalkonium Chloride vs Preservative Free Eye Drops on the Ocular Surface
Active, not recruiting·KKasr El Aini Hospital·Phase 4·NCT06404541·60 enrolled
Dose Response Study of Nitisinone in Alkaptonuria
Completed·UUniversity of Liverpool·Phase 2·NCT01828463·40 enrolled
ALK21-006: Long-Term Study of Medisorb® Naltrexone (VIVITROL®)
Completed·AAlkermes, Inc.·Phase 3·NCT01218997·436 enrolled
Tolerability of ALK Tree Tablet
Completed·AALK-Abelló A/S·Phase 1·NCT00535639
A Long-Term Safety Study of ALKS 5461
Completed·AAlkermes, Inc.·Phase 3·NCT02141399·1,485 enrolled
Safety of ALK Ragweed Tablet
Completed·AALK-Abelló A/S·Phase 1·NCT00330083·72 enrolled
Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy Volunteers
Completed·AAlcon Research·Phase 4·NCT00468988·30 enrolled
A Study of ALKS 5461 in Healthy Volunteers
Completed·AAlkermes, Inc.·Phase 1·NCT02068105·104 enrolled
Drone Biological Samples Transport vs Walking (DBT - Drone Biology Transport)
Completed·UUniversity Hospital, Caen·N/A·NCT05957497·30 enrolled
A Water Consumption Study of ALKS 5461 in Healthy Volunteers
Completed·AAlkermes, Inc.·Phase 1·NCT02521857·30 enrolled
Microdose and First-In-Human (FIH) Study of Recombinant Human Placental Alkaline Phosphatase (hRESCAP)
Completed·TTNO·Phase 1·NCT01889147·4 enrolled
Long-Term Study of Nitisinone to Treat Alkaptonuria
Completed·NNational Human Genome Research Institute (NHGRI)·Phase 2·NCT00107783·40 enrolled
Therapeutic Effect of Crizotinib for Rearrangement-negative, High Phosphorylated ALK Patients
Completed·HHarbin Medical University·N/A·NCT05792644·15 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)